ovispirin-1
General Information
DRACP ID DRACP00020
Peptide Name ovispirin-1
Sequence KNLRRIIRKIIHIIKKYG
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
ME-180 | Human papillomavirus-related cervical squamous cell carcinoma; Squamous cell carcinoma of the cervix uteri | Carcinoma | 100% Cytotoxicity=200 µg/ml | MTT assay | 20h | 1 |
A549 | Lung adenocarcinoma | Carcinoma | 99.7% Cytotoxicity=200 µg/ml | MTT assay | 20h | 1 |
Hemolytic Activity Human erythrocytes: 70% Hemolysis=80 µg/ml
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C105H188N34O21
Absent amino acids ACDEFMPQSTVW
Common amino acids I
Mass 256628
Pl 12.28
Basic residues 8
Acidic residues 0
Hydrophobic residues 7
Net charge 8
Boman Index -4302
Hydrophobicity -37.22
Aliphatic Index 151.67
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 1490
Absorbance 280nm 87.65
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 11932493
Title Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides
Year 2002
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available